Author:
Sun Jenny Y.,Xu Lian,Tseng Hsuyi,Ciccarelli Bryan,Fulciniti Mariateresa,Hunter Zachary R.,Maghsoudi Kaveh,Hatjiharissi Evdoxia,Zhou Yangsheng,Yang Guang,Zhu Biao,Liu Xia,Gong P,Ioakimidis Leukothea,Sheehy Patricia,Patterson Christopher J.,Munshi Nikhil C.,O'Connor Owen A.,Treon Steven P.
Subject
Cancer Research,Oncology,Hematology
Reference23 articles.
1. Diagnosis and management of Waldenstrom's macroglobulinemia;Dimopoulos;J Clin Oncol,2005
2. Waldenstrom's macrogloblinemia/lymphoplasmacytic lymphoma;Treon;Cancer Treat Res,2008
3. Hatjiharissi E, Ciccarelli BT, Zhan FH, et al. Molecular characterization of malignant and microenviromental cells in Waldenstrom's macroglobulinemia by gene expression profiling. Manuscript submitted, 2009.
4. Histone deacetylase inhibitors and genomic instability;Eot-Houllier;Cancer Lett,2009
5. Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group;Chen;J Clin Oncol,2007
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献